pyrazines has been researched along with tretinoin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Honma, Y; Hozumi, M; Nakai, S; Okabe-Kado, J; Sato, S; Tomoyasu, S; Tsuruoka, N | 1 |
| Ali, IU; Herbert, BS; Kopelovich, L; Passons, CM; Shay, JW; Wright, AC; Wright, WE | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Liu, YP; Ma, YJ; Qu, XJ | 1 |
| He, Q; Li, L; Lin, M; Luo, P; Yang, B | 1 |
| Batár, P; Kiss, A; Rejto, L; Reményi, G; Szász, R; Telek, B; Udvardy, M; Ujj, ZÁ | 1 |
| Gu, JL; Huang, BH; Li, J; Liu, JR; Su, C; Zheng, D; Zhou, ZH | 1 |
| Bouyssié, D; Burlet-Schiltz, O; Calligaris, D; Lutz, PG; Monsarrat, B; Uttenweiler-Joseph, S | 1 |
| He, Q; Jing, H; Lin, N; Luo, P; Song, H; Yang, B; Yang, X; Ying, M; Zhong, L; Zhou, X | 1 |
| Fujiwara, S; Hata, H; Kawano, Y; Kikukawa, Y; Mitsuya, H; Okuno, Y; Wada, N | 1 |
| Baek, JH; Choi, Y; Heo, SK; Jo, JC; Kim, H; Koh, S; Min, YJ; Noh, EK; Park, JH; Yoon, DJ | 1 |
| Naoe, T | 1 |
2 review(s) available for pyrazines and tretinoin
| Article | Year |
|---|---|
[Current treatment of acute myeloid leukaemia in adults].
Topics: Age Factors; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mitoxantrone; Molecular Targeted Therapy; Oxides; Prognosis; Pyrazines; Recurrence; Transplantation, Homologous; Treatment Outcome; Tretinoin | 2012 |
＜Editors' Choice＞ How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement.
Topics: Aged; Aged, 80 and over; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Arsenic Trioxide; Azacitidine; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Decitabine; fms-Like Tyrosine Kinase 3; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Phenylurea Compounds; Precision Medicine; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Smoothened Receptor; Staurosporine; Sulfonamides; Survival Rate; Tretinoin; Triazines | 2020 |
10 other study(ies) available for pyrazines and tretinoin
| Article | Year |
|---|---|
Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium; Cardiotonic Agents; Cell Differentiation; Drug Interactions; Drug Resistance; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Muramidase; Pyrazines; Quinolines; Stimulation, Chemical; Tretinoin; Tumor Cells, Cultured; Vincristine | 1996 |
Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Disease Progression; DNA, Complementary; Eflornithine; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Female; Humans; Li-Fraumeni Syndrome; Oligodeoxyribonucleotides, Antisense; Point Mutation; Pyrazines; Reverse Transcriptase Inhibitors; Tamoxifen; Telomerase; Thiones; Thiophenes; Transformation, Genetic; Tretinoin | 2001 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
[The influence of bortezomib on HL-60 cell function induced by all-trans retinoic acid plus bufalin and its mechanism].
Topics: Boronic Acids; Bortezomib; Bufanolides; Cell Adhesion; Cell Proliferation; Focal Adhesion Kinase 2; HL-60 Cells; Humans; Paxillin; Pyrazines; Tretinoin | 2008 |
The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cell Differentiation; Cell Line, Tumor; Drug Synergism; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Neuroblastoma; Protease Inhibitors; Pyrazines; Rats; Tretinoin; Xenograft Model Antitumor Assays | 2011 |
Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Differentiation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Estradiol; Humans; Multiple Myeloma; Pyrazines; Regulatory Factor X Transcription Factors; Transcription Factors; Tretinoin; Tumor Cells, Cultured; X-Box Binding Protein 1 | 2012 |
Quantitative proteomic analysis to decipher the differential apoptotic response of bortezomib-treated APL cells before and after retinoic acid differentiation reveals involvement of protein toxicity mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Line, Tumor; Evaluation Studies as Topic; Humans; Leukemia, Promyelocytic, Acute; Peptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteins; Pyrazines; Receptors, Retinoic Acid; Stress, Physiological; Tretinoin; Ubiquitin | 2013 |
Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Proliferation; Drug Synergism; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Nude; Pyrazines; Random Allocation; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; STAT1 Transcription Factor; Tretinoin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.
Topics: Aldehyde Oxidoreductases; Antigens, CD20; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Differentiation; Cell Hypoxia; Cell Line, Tumor; Down-Regulation; Humans; Intercellular Signaling Peptides and Proteins; Multiple Myeloma; Neoplastic Stem Cells; Oxygen; PAX5 Transcription Factor; Peptides; Pyrazines; Receptors, CXCR4; Syndecan-1; Tretinoin; Tumor Microenvironment | 2013 |
Radotinib Induces Apoptosis of CD11b+ Cells Differentiated from Acute Myeloid Leukemia Cells.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Benzamides; CD11b Antigen; Cell Line, Tumor; Female; Humans; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazines; src-Family Kinases; Tretinoin | 2015 |